Achieve Life Sciences

OverviewSuggest Edit

Achieve Life Sciences is a biopharmaceutical company that develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The Company is also working on cytisine-based therapies as a widely available treatment option for nicotine addiction.

TypePublic
Founded1995
HQSeattle, US
Websiteachievelifesciences.com

Latest Updates

Employees (est.) (Dec 2019)14(+8%)
Revenue (FY, 2019)$0
Share Price (Nov 2020)$9.4 (-9%)
Cybersecurity ratingAMore

Key People/Management at Achieve Life Sciences

Richard Stewart

Richard Stewart

Chairman and Chief Executive Officer
Scott Cormack

Scott Cormack

President & Chief Executive Officer, Director
John Bencich

John Bencich

Executive VP, Chief Financial and Operating Officer
Anthony Clarke

Anthony Clarke

President, Chief Scientific Officer, Director
Cindy Jacobs

Cindy Jacobs

Executive VP and Chief Medical Officer
Kirsten Anderson

Kirsten Anderson

Vice President, Clinical Operations
Show more

Achieve Life Sciences Office Locations

Achieve Life Sciences has offices in Seattle, Bothell and Vancouver
Seattle, US (HQ)
520 Pike St #2250
Bothell, US
19820 North Creek Pkwy #201
Vancouver, CA
1040 W Georgia St #1030
Show all (3)

Achieve Life Sciences Financials and Metrics

Achieve Life Sciences Revenue

USD

Net income (Q2, 2020)

(2.9m)

Market capitalization (17-Nov-2020)

33.8m

Closing stock price (17-Nov-2020)

9.4

Cash (30-Jun-2020)

12.1m

EV

22.0m
Achieve Life Sciences's current market capitalization is $33.8 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

General and administrative expense

6.2m7.8m9.9m10.6m11.8m8.9m3.5m6.9m6.9m

R&D expense

21.6m39.9m55.3m46.2m25.1m14.8m3.1m5.9m9.7m

Operating expense total

27.8m49.4m65.2m56.8m36.9m23.7m6.6m12.8m16.5m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

General and administrative expense

1.5m1.5m1.7m2.0m2.0m2.5m2.5m2.5m2.8m2.7m2.5m2.7m3.1m3.1m2.3m2.5m1.9m2.5m2.3m1.6m1.8m1.8m1.8m1.9m1.6m1.9m1.8m1.8m

R&D expense

5.4m3.8m5.1m6.3m12.9m10.9m13.3m18.0m16.9m9.9m9.6m3.7m6.5m8.3m4.6m4.7m3.8m912.0k777.0k825.0k1.2m1.0m1.5m4.1m2.0m1.8m1.5m1.1m

Operating expense total

6.9m5.3m6.8m8.4m14.9m13.4m15.7m20.5m19.7m12.6m12.0m6.4m9.6m11.4m7.4m7.1m5.6m3.4m3.1m2.4m3.0m2.8m3.3m5.9m3.7m3.7m3.4m2.9m

EBIT

(5.0m)(4.1m)(5.5m)5.9m8.3m
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

28.5m18.1m14.6m27.9m34.3m15.2m5.3m9.5m16.7m

Accounts Receivable

812.0k714.0k8.7m5.7m14.0k32.0k9.0k7.0k8.0k

Prepaid Expenses

1.2m3.8m5.8m2.2m2.0m393.0k926.0k662.0k

Inventories

USDQ2, 2011

Financial Leverage

2.3 x
Show all financial metrics

Achieve Life Sciences Cybersecurity Score

Cybersecurity ratingPremium dataset

A

97/100

SecurityScorecard logo

Achieve Life Sciences Online and Social Media Presence

Embed Graph

Achieve Life Sciences News and Updates

Achieve Life Sciences Announces Start of Phase 3 ORCA-2 Clinical Trial Evaluating Cytisinicline for Smoking Cessation

SEATTLE and VANCOUVER, B.C., Oct. 7, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced initiation...

Achieve Life Sciences Announces Presentation of Cytisinicline Data at the 20th Annual Society for Research on Nicotine & Tobacco Europe (SRNT-E) Virtual Conference

SEATTLE and VANCOUVER, BC, Sept. 10, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that cytisinicline data will be...

Achieve Life Sciences to Present at Upcoming Investor Conferences

SEATTLE and VANCOUVER, BC, Sept. 3, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that it will present at two...

Thinking about buying stock in Achieve Life Sciences, Applied DNA Sciences, Delta Air Lines, Carnival Corp, or MGM Resorts?

NEW YORK, July 31, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACHV, APDN, DAL, CCL, and MGM. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about buying stock in Achieve Life Sciences, Regulus Therapeutics, Exela Technologies, FireEye Inc, or Intel Corp?

NEW YORK, July 29, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACHV, RGLS, XELA, FEYE, and INTC. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about buying stock in Achieve Life Sciences, Regulus Therapeutics, Exela Technologies, FireEye Inc, or Intel Corp?

NEW YORK, July 29, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACHV, RGLS, XELA, FEYE, and INTC. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....
Show more

Achieve Life Sciences Blogs

Achieve Life Sciences Announces Pricing of $15 Million Public Offering

SEATTLE, Wash. and VANCOUVER, British Columbia, December 3, 2020 -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced the pricing…

Five Tips to Help You Nip Smoking in the “Butt”

It’s always a good time to quit smoking, but now more than ever is an important time to jumpstart your quit date and make a plan to quit smoking. A smoke-free lifestyle is always within reach, and we at Achieve Life Sciences are proud to share five key practicable tips to help you start the [...]

Achieve Reports Financial Results for Third Quarter 2020 and Provides Corporate and Cytisinicline Development Update

SEATTLE, Wash and VANCOUVER, British Columbia, November 12, 2020 -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced third quart…

Achieve Life Sciences to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 12, 2020

SEATTLE, Wash. and VANCOUVER, British Columbia, October 29, 2020 -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that it wil…

Achieve Life Sciences to Host Smoking Cessation Key Opinion Leader Virtual Roundtable on November 17th, 2020

SEATTLE, Wash and VANCOUVER, British Columbia, October 27, 2020 -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced the Company …

Achieve Life Sciences Shareholder Letter – October 2020

October 22, 2020 Dear Fellow Shareholders, We hope this letter finds you and your families safe and healthy. Given that we continue to live in unprecedented times, faced with uncertainty and unique challenges, John and I thought it was appropriate to reach out with an update on the company’s progres…
Show more

Achieve Life Sciences Frequently Asked Questions

  • When was Achieve Life Sciences founded?

    Achieve Life Sciences was founded in 1995.

  • Who are Achieve Life Sciences key executives?

    Achieve Life Sciences's key executives are Richard Stewart, Scott Cormack and John Bencich.

  • How many employees does Achieve Life Sciences have?

    Achieve Life Sciences has 14 employees.

  • Who are Achieve Life Sciences competitors?

    Competitors of Achieve Life Sciences include Karo Pharma, Sareum Holdings and tella.

  • Where is Achieve Life Sciences headquarters?

    Achieve Life Sciences headquarters is located at 520 Pike St #2250, Seattle.

  • Where are Achieve Life Sciences offices?

    Achieve Life Sciences has offices in Seattle, Bothell and Vancouver.

  • How many offices does Achieve Life Sciences have?

    Achieve Life Sciences has 3 offices.